COVID-19

News

Pandemic hits sales at Novartis after strong launch for SMA ...

The COVID-19 pandemic has bit into sales at Novartis, the big Swiss pharma said in second quarter results, after orders fell back following a period of stockpiling earlier in the year.

News

Blood sample with respiratory coronavirus positive

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

The UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses if they check out in trials.

News

Synairgen's inhaled drug cuts chances of COVID-19 progressin...

An inhaled drug developed by the UK firm Synairgen greatly reduces the chances of patients hospitalised with COVID-19 from progressing to more serious stages of the disease.

News

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Press reports suggest that there is good news about AstraZeneca and Oxford University’s COVID-19 vaccine due from an early stage trial in the coming days – but the focus is moving on how to

Views & Analysis

Coronavirus pharma news roundup - 17/07/20

Coronavirus vaccine trials continue – but experts warn that it’s too early to get hopes up. Meanwhile, the rise in digital health looks like it’s here to stay after the pandemic.

Views & Analysis

ICMRA seeks international alignment on COVID-19 product asse...

COVID-19 drugs, vaccines and diagnostics that are developed and tested within new international guidelines can expect rapid assessment and authorisation.

Pandemic hits sales at Novartis after strong launch for SMA ...

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

Synairgen's inhaled drug cuts chances of COVID-19 progressin...

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Coronavirus pharma news roundup - 17/07/20

ICMRA seeks international alignment on COVID-19 product asse...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks